Dear Editor,The emergence of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection requires rapid development of vaccines matching the pace of virus mutation.While the firstgeneration of nucleic aci...Dear Editor,The emergence of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection requires rapid development of vaccines matching the pace of virus mutation.While the firstgeneration of nucleic acid vaccines have been successful,subunit vaccines carry far fewer safety concerns and also have shown promise in clinical trials.展开更多
基金the National Natural Science Foundation of China(Grant No.82072049)China Postdoctoral Science Foundation(No.2020M672641)+2 种基金Natural Science Foundation of Guangdong Province,China(No.2021A1515010408)Guangzhou Basic and Applied Basic Research Foundation(No.202102020322)The Fundamental Research Funds for the Central Universities.
文摘Dear Editor,The emergence of the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection requires rapid development of vaccines matching the pace of virus mutation.While the firstgeneration of nucleic acid vaccines have been successful,subunit vaccines carry far fewer safety concerns and also have shown promise in clinical trials.
